LINAMET 2.5/500MG TAB

Linamet 2.5/500mg Tablet is a fixed-dose combination antidiabetic formulation combining linagliptin and metformin for comprehensive type 2 diabetes management. Each tablet delivers 2.5mg linagliptin (DPP-4 inhibitor) and 500mg metformin, utilizing complementary mechanisms to optimize glycemic control. Linagliptin enhances incretin-mediated insulin secretion while metformin improves insulin sensitivity and suppresses hepatic glucose production. This synergistic approach effectively reduces postprandial and fasting blood glucose levels in patients with inadequate monotherapy response. The combination formulation streamlines medication regimens, enhancing patient compliance and convenience. Particularly valuable for patients requiring intensified glucose management or those transitioning from multiple separate medications. Regular HbA1c monitoring and renal function assessment are recommended during therapy. Consult your healthcare provider regarding appropriate dosing schedules, dietary modifications, and potential drug interactions before initiating treatment.